3O2X - JenaLib

Asymmetric Unit (5, 31)

No.	Name	Count	Type	Full Name
1	3O2	4	Ligand/Ion	N-HYDROXY-1-(2-METHOXYETHYL)-4-{[4-(3-{5-[4-(TRIFLUOROMETHOXY)PHENYL]-2H-TETRAZOL-2-YL}PROPOXY)PHENYL]SULFONYL}PIPERIDINE-4-CARBOXAMIDE
2	CA	8	Ligand/Ion	CALCIUM ION
3	EPE	2	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
4	SO4	9	Ligand/Ion	SULFATE ION
5	ZN	8	Ligand/Ion	ZINC ION

Biological Unit 1 (3, 5)

No.	Name	Count	Type	Full Name
1	3O2	1	Ligand/Ion	N-HYDROXY-1-(2-METHOXYETHYL)-4-{[4-(3-{5-[4-(TRIFLUOROMETHOXY)PHENYL]-2H-TETRAZOL-2-YL}PROPOXY)PHENYL]SULFONYL}PIPERIDINE-4-CARBOXAMIDE
2	CA	-1	Ligand/Ion	CALCIUM ION
3	EPE	1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
4	SO4	3	Ligand/Ion	SULFATE ION
5	ZN	-1	Ligand/Ion	ZINC ION

Biological Unit 2 (3, 5)

No.	Name	Count	Type	Full Name
1	3O2	1	Ligand/Ion	N-HYDROXY-1-(2-METHOXYETHYL)-4-{[4-(3-{5-[4-(TRIFLUOROMETHOXY)PHENYL]-2H-TETRAZOL-2-YL}PROPOXY)PHENYL]SULFONYL}PIPERIDINE-4-CARBOXAMIDE
2	CA	-1	Ligand/Ion	CALCIUM ION
3	EPE	1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
4	SO4	3	Ligand/Ion	SULFATE ION
5	ZN	-1	Ligand/Ion	ZINC ION

Biological Unit 3 (2, 2)

No.	Name	Count	Type	Full Name
1	3O2	1	Ligand/Ion	N-HYDROXY-1-(2-METHOXYETHYL)-4-{[4-(3-{5-[4-(TRIFLUOROMETHOXY)PHENYL]-2H-TETRAZOL-2-YL}PROPOXY)PHENYL]SULFONYL}PIPERIDINE-4-CARBOXAMIDE
2	CA	-1	Ligand/Ion	CALCIUM ION
3	EPE	-1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
4	SO4	1	Ligand/Ion	SULFATE ION
5	ZN	-1	Ligand/Ion	ZINC ION

Biological Unit 4 (2, 3)

No.	Name	Count	Type	Full Name
1	3O2	1	Ligand/Ion	N-HYDROXY-1-(2-METHOXYETHYL)-4-{[4-(3-{5-[4-(TRIFLUOROMETHOXY)PHENYL]-2H-TETRAZOL-2-YL}PROPOXY)PHENYL]SULFONYL}PIPERIDINE-4-CARBOXAMIDE
2	CA	-1	Ligand/Ion	CALCIUM ION
3	EPE	-1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
4	SO4	2	Ligand/Ion	SULFATE ION
5	ZN	-1	Ligand/Ion	ZINC ION

Biological Unit 5 (3, 8)

No.	Name	Count	Type	Full Name
1	3O2	2	Ligand/Ion	N-HYDROXY-1-(2-METHOXYETHYL)-4-{[4-(3-{5-[4-(TRIFLUOROMETHOXY)PHENYL]-2H-TETRAZOL-2-YL}PROPOXY)PHENYL]SULFONYL}PIPERIDINE-4-CARBOXAMIDE
2	CA	-1	Ligand/Ion	CALCIUM ION
3	EPE	1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
4	SO4	5	Ligand/Ion	SULFATE ION
5	ZN	-1	Ligand/Ion	ZINC ION

Biological Unit 6 (3, 7)

No.	Name	Count	Type	Full Name
1	3O2	2	Ligand/Ion	N-HYDROXY-1-(2-METHOXYETHYL)-4-{[4-(3-{5-[4-(TRIFLUOROMETHOXY)PHENYL]-2H-TETRAZOL-2-YL}PROPOXY)PHENYL]SULFONYL}PIPERIDINE-4-CARBOXAMIDE
2	CA	-1	Ligand/Ion	CALCIUM ION
3	EPE	1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
4	SO4	4	Ligand/Ion	SULFATE ION
5	ZN	-1	Ligand/Ion	ZINC ION

Biological Unit 7 (3, 8)

No.	Name	Count	Type	Full Name
1	3O2	2	Ligand/Ion	N-HYDROXY-1-(2-METHOXYETHYL)-4-{[4-(3-{5-[4-(TRIFLUOROMETHOXY)PHENYL]-2H-TETRAZOL-2-YL}PROPOXY)PHENYL]SULFONYL}PIPERIDINE-4-CARBOXAMIDE
2	CA	-1	Ligand/Ion	CALCIUM ION
3	EPE	1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
4	SO4	5	Ligand/Ion	SULFATE ION
5	ZN	-1	Ligand/Ion	ZINC ION

Sites (31, 31)

Asymmetric Unit (31, 31)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	HOH A:26 , EPE A:400 , HOH A:424 , HOH A:604 , HOH A:829 , LEU A:1184 , LEU A:1185 , ALA A:1186 , LEU A:1218 , HIS A:1222 , GLU A:1223 , HIS A:1226 , HIS A:1232 , LEU A:1239 , PHE A:1241 , PRO A:1242 , ILE A:1243 , THR A:1245 , TYR A:1246 , MET A:1253 , ZN A:1999	BINDING SITE FOR RESIDUE 3O2 A 1801
02	AC2	SOFTWARE	HOH B:41 , EPE B:400 , HOH B:453 , HOH B:609 , HOH B:892 , HOH B:894 , LEU B:2185 , ALA B:2186 , HIS B:2222 , GLU B:2223 , HIS B:2226 , HIS B:2232 , LEU B:2239 , PHE B:2241 , PRO B:2242 , TYR B:2244 , THR B:2245 , GLY B:2248 , HIS B:2251 , PHE B:2252 , MET B:2253 , ZN B:2999	BINDING SITE FOR RESIDUE 3O2 B 1801
03	AC3	SOFTWARE	HOH C:46 , HOH C:267 , HOH C:464 , GLY C:1183 , LEU C:1185 , ALA C:1186 , LEU C:1218 , HIS C:1222 , GLU C:1223 , HIS C:1226 , HIS C:1232 , LEU C:1239 , PHE C:1241 , PRO C:1242 , ILE C:1243 , TYR C:1244 , THR C:1245 , HIS C:1251 , PHE C:1252 , MET C:1253 , ZN C:1999	BINDING SITE FOR RESIDUE 3O2 C 1801
04	AC4	SOFTWARE	HOH D:86 , HOH D:338 , HOH D:837 , GLY D:2183 , LEU D:2185 , ALA D:2186 , HIS D:2222 , GLU D:2223 , HIS D:2226 , HIS D:2232 , ALA D:2238 , LEU D:2239 , PHE D:2241 , PRO D:2242 , ILE D:2243 , TYR D:2244 , THR D:2245 , GLY D:2248 , PHE D:2252 , MET D:2253 , ZN D:2999	BINDING SITE FOR RESIDUE 3O2 D 1801
05	AC5	SOFTWARE	HIS A:1172 , ASP A:1174 , HIS A:1187 , HIS A:1200	BINDING SITE FOR RESIDUE ZN A 1998
06	AC6	SOFTWARE	HIS A:1222 , HIS A:1226 , HIS A:1232 , 3O2 A:1801	BINDING SITE FOR RESIDUE ZN A 1999
07	AC7	SOFTWARE	HOH A:167 , HOH A:479 , ALA A:1161 , ASP A:1162 , ASN A:1194 , GLY A:1196 , ASP A:1198	BINDING SITE FOR RESIDUE CA A 1996
08	AC8	SOFTWARE	ASP A:1179 , GLY A:1180 , SER A:1182 , LEU A:1184 , ASP A:1202 , GLU A:1205	BINDING SITE FOR RESIDUE CA A 1997
09	AC9	SOFTWARE	HIS B:2172 , ASP B:2174 , HIS B:2187 , HIS B:2200	BINDING SITE FOR RESIDUE ZN B 2998
10	BC1	SOFTWARE	3O2 B:1801 , HIS B:2222 , HIS B:2226 , HIS B:2232	BINDING SITE FOR RESIDUE ZN B 2999
11	BC2	SOFTWARE	HOH B:435 , ASP B:2162 , ASN B:2194 , GLY B:2196 , ASP B:2198	BINDING SITE FOR RESIDUE CA B 2996
12	BC3	SOFTWARE	ASP B:2179 , GLY B:2180 , SER B:2182 , LEU B:2184 , ASP B:2202 , GLU B:2205	BINDING SITE FOR RESIDUE CA B 2997
13	BC4	SOFTWARE	HIS C:1172 , ASP C:1174 , HIS C:1187 , HIS C:1200	BINDING SITE FOR RESIDUE ZN C 1998
14	BC5	SOFTWARE	HIS C:1222 , HIS C:1226 , HIS C:1232 , 3O2 C:1801	BINDING SITE FOR RESIDUE ZN C 1999
15	BC6	SOFTWARE	HOH C:185 , HOH C:256 , ASP C:1162 , ASN C:1194 , GLY C:1196 , ASP C:1198	BINDING SITE FOR RESIDUE CA C 1996
16	BC7	SOFTWARE	ASP C:1179 , GLY C:1180 , SER C:1182 , LEU C:1184 , ASP C:1202 , GLU C:1205	BINDING SITE FOR RESIDUE CA C 1997
17	BC8	SOFTWARE	HIS D:2172 , ASP D:2174 , HIS D:2187 , HIS D:2200	BINDING SITE FOR RESIDUE ZN D 2998
18	BC9	SOFTWARE	3O2 D:1801 , HIS D:2222 , HIS D:2226 , HIS D:2232	BINDING SITE FOR RESIDUE ZN D 2999
19	CC1	SOFTWARE	HOH D:62 , ASP D:2162 , ASN D:2194 , GLY D:2196 , ASP D:2198	BINDING SITE FOR RESIDUE CA D 2996
20	CC2	SOFTWARE	ASP D:2179 , GLY D:2180 , SER D:2182 , LEU D:2184 , ASP D:2202 , GLU D:2205	BINDING SITE FOR RESIDUE CA D 2997
21	CC3	SOFTWARE	HOH C:111 , HOH C:533 , TYR C:1120 , LYS C:1139 , ARG C:1155	BINDING SITE FOR RESIDUE SO4 C 1
22	CC4	SOFTWARE	HOH A:134 , HOH A:136 , HOH A:192 , HOH A:721 , HOH A:826 , TYR A:1120 , LYS A:1139 , ARG A:1155	BINDING SITE FOR RESIDUE SO4 A 2
23	CC5	SOFTWARE	HOH B:36 , HOH B:188 , THR B:2130 , HIS B:2131 , THR D:2130 , HIS D:2131	BINDING SITE FOR RESIDUE SO4 B 3
24	CC6	SOFTWARE	HOH B:291 , TYR B:2120 , LYS B:2136 , LYS B:2139 , ARG B:2155	BINDING SITE FOR RESIDUE SO4 B 4
25	CC7	SOFTWARE	HOH D:76 , HOH D:774 , TYR D:2120 , LYS D:2139 , ARG D:2155	BINDING SITE FOR RESIDUE SO4 D 5
26	CC8	SOFTWARE	HOH B:912 , LYS B:2115 , MET B:2116 , ASN B:2117	BINDING SITE FOR RESIDUE SO4 B 6
27	CC9	SOFTWARE	LYS A:1115 , MET A:1116 , ASN A:1117	BINDING SITE FOR RESIDUE SO4 A 7
28	DC1	SOFTWARE	HOH C:880 , HOH D:843 , HOH D:903 , LYS D:2115 , MET D:2116 , ASN D:2117	BINDING SITE FOR RESIDUE SO4 D 8
29	DC2	SOFTWARE	HOH A:131 , HOH A:659 , HOH A:841 , THR A:1130 , HIS A:1131 , HOH C:199 , THR C:1130 , HIS C:1131	BINDING SITE FOR RESIDUE SO4 A 9
30	DC3	SOFTWARE	HOH A:232 , HOH A:259 , HOH A:383 , HIS A:1187 , ALA A:1188 , PHE A:1189 , 3O2 A:1801 , ASN D:2194	BINDING SITE FOR RESIDUE EPE A 400
31	DC4	SOFTWARE	HOH B:455 , HOH B:589 , 3O2 B:1801 , TYR B:2176 , LEU B:2184 , HIS B:2187 , ALA B:2188 , PHE B:2189 , ASN C:1194	BINDING SITE FOR RESIDUE EPE B 400

SS Bonds (0, 0)

Cis Peptide Bonds (7, 7)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (2, 8)

Asymmetric Unit (2, 8)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_073418	W	207	G	MMP13_HUMAN	Disease (MDST)	140059558	A/C B/D	W	1207 2207	G
2	UniProt	VAR_063434	H	232	N	MMP13_HUMAN	Disease (MANDP1)	121909500	A/C B/D	H	1232 2232	N

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (2, 2)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_073418	W	207	G	MMP13_HUMAN	Disease (MDST)	140059558	A/C A	W	1207 2207	G
2	UniProt	VAR_063434	H	232	N	MMP13_HUMAN	Disease (MANDP1)	121909500	A/C A	H	1232 2232	N

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (2, 2)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_073418	W	207	G	MMP13_HUMAN	Disease (MDST)	140059558	A/C B	W	1207 2207	G
2	UniProt	VAR_063434	H	232	N	MMP13_HUMAN	Disease (MANDP1)	121909500	A/C B	H	1232 2232	N

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 3 (2, 2)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_073418	W	207	G	MMP13_HUMAN	Disease (MDST)	140059558	A/C C	W	1207 2207	G
2	UniProt	VAR_063434	H	232	N	MMP13_HUMAN	Disease (MANDP1)	121909500	A/C C	H	1232 2232	N

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 4 (2, 2)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_073418	W	207	G	MMP13_HUMAN	Disease (MDST)	140059558	A/C D	W	1207 2207	G
2	UniProt	VAR_063434	H	232	N	MMP13_HUMAN	Disease (MANDP1)	121909500	A/C D	H	1232 2232	N

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 5 (2, 8)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_073418	W	207	G	MMP13_HUMAN	Disease (MDST)	140059558	A/C A/B/C/D	W	1207 2207	G
2	UniProt	VAR_063434	H	232	N	MMP13_HUMAN	Disease (MANDP1)	121909500	A/C A/B/C/D	H	1232 2232	N

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 6 (2, 4)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_073418	W	207	G	MMP13_HUMAN	Disease (MDST)	140059558	A/C A/C	W	1207 2207	G
2	UniProt	VAR_063434	H	232	N	MMP13_HUMAN	Disease (MANDP1)	121909500	A/C A/C	H	1232 2232	N

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 7 (2, 4)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_073418	W	207	G	MMP13_HUMAN	Disease (MDST)	140059558	A/C B/D	W	1207 2207	G
2	UniProt	VAR_063434	H	232	N	MMP13_HUMAN	Disease (MANDP1)	121909500	A/C B/D	H	1232 2232	N

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (1, 4)

Exons (5, 20)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:164
 aligned with MMP13_HUMAN | P45452 from UniProtKB/Swiss-Prot  Length:471

    Alignment length:164
                                   113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263    
         MMP13_HUMAN    104 YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYG  267
               SCOP domains d3o2xa_ A: Collagenase-3 (MMP-13)                                                                                                                                    SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .............eeeeee.......hhhhhhhhhhhhhhhhhh....eeeee......eeeeee.................eee..........eeee....ee.....eehhhhhhhhhhhhh..........................hhhhhhhhhhhhh Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------------------------------ZINC_PROTE--------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2          -------------------------------------------------Exon 1.4  PDB: A:1171-1213 UniProt: 171-213-----------------------------------------------------1 Transcript 1 (1)
           Transcript 1 (2) -----------------Exon 1.3  PDB: A:1121-1171 UniProt: 121-171        -----------------------------------------Exon 1.5  PDB: A:1213-1267 UniProt: 213-267             Transcript 1 (2)
                3o2x A 1104 ANVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYG 1267
                                  1113      1123      1133      1143      1153      1163      1173      1183      1193      1203      1213      1223      1233      1243      1253      1263

Chain B from PDB  Type:PROTEIN  Length:164
 aligned with MMP13_HUMAN | P45452 from UniProtKB/Swiss-Prot  Length:471

    Alignment length:164
                                   113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263    
         MMP13_HUMAN    104 YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYG  267
               SCOP domains d3o2xb_ B: Collagenase-3 (MMP-13)                                                                                                                                    SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .............eeeeee.......hhhhhhhhhhhhhhhhhh....eeeee......eeeeee.................eee..........eeee....ee.....eehhhhhhhhhhhhhh.........................hhhhhhhhhhhhh Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------G------------------------N----------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------------------------------ZINC_PROTE--------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2          -------------------------------------------------Exon 1.4  PDB: B:2171-2213 UniProt: 171-213-----------------------------------------------------1 Transcript 1 (1)
           Transcript 1 (2) -----------------Exon 1.3  PDB: B:2121-2171 UniProt: 121-171        -----------------------------------------Exon 1.5  PDB: B:2213-2267 UniProt: 213-267             Transcript 1 (2)
                3o2x B 2104 ANVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYG 2267
                                  2113      2123      2133      2143      2153      2163      2173      2183      2193      2203      2213      2223      2233      2243      2253      2263

Chain C from PDB  Type:PROTEIN  Length:164
 aligned with MMP13_HUMAN | P45452 from UniProtKB/Swiss-Prot  Length:471

    Alignment length:164
                                   113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263    
         MMP13_HUMAN    104 YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYG  267
               SCOP domains d3o2xc_ C: Collagenase-3 (MMP-13)                                                                                                                                    SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .............eeeeee.......hhhhhhhhhhhhhhhhhh....eeee.......eeeeee.................eee..........eeee....ee.....eehhhhhhhhhhhhhh.........................hhhhhhhhhhhhh Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------------------------------ZINC_PROTE--------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2          -------------------------------------------------Exon 1.4  PDB: C:1171-1213 UniProt: 171-213-----------------------------------------------------1 Transcript 1 (1)
           Transcript 1 (2) -----------------Exon 1.3  PDB: C:1121-1171 UniProt: 121-171        -----------------------------------------Exon 1.5  PDB: C:1213-1267 UniProt: 213-267             Transcript 1 (2)
                3o2x C 1104 ANVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYG 1267
                                  1113      1123      1133      1143      1153      1163      1173      1183      1193      1203      1213      1223      1233      1243      1253      1263

Chain D from PDB  Type:PROTEIN  Length:164
 aligned with MMP13_HUMAN | P45452 from UniProtKB/Swiss-Prot  Length:471

    Alignment length:164
                                   113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263    
         MMP13_HUMAN    104 YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYG  267
               SCOP domains d3o2xd_ D: Collagenase-3 (MMP-13)                                                                                                                                    SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .............eeeeee.......hhhhhhhhhhhhhhhhhh....eeeee......eeeeee.................eee..........eeee....ee.....eehhhhhhhhhhhhhh.........................hhhhhhhhhhhhh Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------G------------------------N----------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------------------------------ZINC_PROTE--------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2          -------------------------------------------------Exon 1.4  PDB: D:2171-2213 UniProt: 171-213-----------------------------------------------------1 Transcript 1 (1)
           Transcript 1 (2) -----------------Exon 1.3  PDB: D:2121-2171 UniProt: 121-171        -----------------------------------------Exon 1.5  PDB: D:2213-2267 UniProt: 213-267             Transcript 1 (2)
                3o2x D 2104 ANVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYG 2267
                                  2113      2123      2133      2143      2153      2163      2173      2183      2193      2203      2213      2223      2233      2243      2253      2263

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (1, 4)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (42, 42)

Asymmetric Unit(hide GO term definitions)

Chain A,B,C,D (MMP13_HUMAN | P45452)

molecular function
	GO:0005509	calcium ion binding	Interacting selectively and non-covalently with calcium ions (Ca2+).
	GO:0048306	calcium-dependent protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules), in the presence of calcium.
	GO:0005518	collagen binding	Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
	GO:0001968	fibronectin binding	Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0050750	low-density lipoprotein particle receptor binding	Interacting selectively and non-covalently with a low-density lipoprotein receptor.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0004222	metalloendopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
	GO:0008237	metallopeptidase activity	Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
	GO:0008233	peptidase activity	Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
	GO:0004252	serine-type endopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
	GO:0008270	zinc ion binding	Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
	GO:0030282	bone mineralization	The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue.
	GO:0060349	bone morphogenesis	The process in which bones are generated and organized.
	GO:0051216	cartilage development	The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
	GO:0044267	cellular protein metabolic process	The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
	GO:0071498	cellular response to fluid shear stress	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.
	GO:0030574	collagen catabolic process	The proteolytic chemical reactions and pathways resulting in the breakdown of collagen in the extracellular matrix, usually carried out by proteases secreted by nearby cells.
	GO:0035116	embryonic hindlimb morphogenesis	The process, occurring in the embryo, by which the anatomical structures of the hindlimbs are generated and organized. The hindlimbs are the posterior limbs of an animal.
	GO:0001958	endochondral ossification	Replacement ossification wherein bone tissue replaces cartilage.
	GO:0044849	estrous cycle	A type of ovulation cycle, which occurs in most mammalian therian females, where the endometrium is resorbed if pregnancy does not occur.
	GO:0022617	extracellular matrix disassembly	A process that results in the breakdown of the extracellular matrix.
	GO:0003417	growth plate cartilage development	The process whose specific outcome is the progression of the cartilage that will provide a scaffold for mineralization of endochondral bones as they elongate or grow.
	GO:0007507	heart development	The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
	GO:0001554	luteolysis	The lysis or structural demise of the corpus luteum. During normal luteolysis, two closely related events occur. First, there is loss of the capacity to synthesize and secrete progesterone (functional luteolysis) followed by loss of the cells that comprise the corpus luteum (structural luteolysis). Preventing luteolysis is crucial to maintain pregnancy.
	GO:0001503	ossification	The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
	GO:0001649	osteoblast differentiation	The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
	GO:0007567	parturition	The reproductive process in which the parent is separated from its offspring either by giving birth to live young or by laying eggs.
	GO:0043171	peptide catabolic process	The chemical reactions and pathways resulting in the breakdown of peptides, compounds of 2 or more (but usually less than 100) amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another.
	GO:1904244	positive regulation of pancreatic trypsinogen secretion	Any process that activates or increases the frequency, rate or extent of pancreatic trypsinogen secretion.
	GO:0006508	proteolysis	The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
	GO:0042493	response to drug	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
	GO:0043627	response to estrogen	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
	GO:0001666	response to hypoxia	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
	GO:0009612	response to mechanical stimulus	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
cellular component
	GO:0005794	Golgi apparatus	A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
	GO:0031012	extracellular matrix	A structure lying external to one or more cells, which provides structural support for cells or tissues.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0046581	intercellular canaliculus	An extremely narrow tubular channel located between adjacent cells. An instance of this is the secretory canaliculi occurring between adjacent parietal cells in the gastric mucosa of vertebrates.
	GO:0005764	lysosome	A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
	GO:0005578	proteinaceous extracellular matrix	A layer consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or overlying cells such as endothelial and epithelial cells. The proteins are secreted by cells in the vicinity. An example of this component is found in Mus musculus.

Visualization

Interactive Views

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		3O2	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		CA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		EPE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		SO4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		ZN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]
		BC3	[ RasMol ]	+environment [ RasMol ]
		BC4	[ RasMol ]	+environment [ RasMol ]
		BC5	[ RasMol ]	+environment [ RasMol ]
		BC6	[ RasMol ]	+environment [ RasMol ]
		BC7	[ RasMol ]	+environment [ RasMol ]
		BC8	[ RasMol ]	+environment [ RasMol ]
		BC9	[ RasMol ]	+environment [ RasMol ]
		CC1	[ RasMol ]	+environment [ RasMol ]
		CC2	[ RasMol ]	+environment [ RasMol ]
		CC3	[ RasMol ]	+environment [ RasMol ]
		CC4	[ RasMol ]	+environment [ RasMol ]
		CC5	[ RasMol ]	+environment [ RasMol ]
		CC6	[ RasMol ]	+environment [ RasMol ]
		CC7	[ RasMol ]	+environment [ RasMol ]
		CC8	[ RasMol ]	+environment [ RasMol ]
		CC9	[ RasMol ]	+environment [ RasMol ]
		DC1	[ RasMol ]	+environment [ RasMol ]
		DC2	[ RasMol ]	+environment [ RasMol ]
		DC3	[ RasMol ]	+environment [ RasMol ]
		DC4	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Arg A:1109 - Thr A:1110	[ RasMol ]
		Arg B:2109 - Thr B:2110	[ RasMol ]
		Gly B:2248 - Lys B:2249	[ RasMol ]
		Lys A:1249 - Ser A:1250	[ RasMol ]
		Ser C:1250 - His C:1251	[ RasMol ]
		Thr B:2247 - Gly B:2248	[ RasMol ]
		Tyr B:2246 - Thr B:2247	[ RasMol ]

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]
		Biological Unit 3	[ Jena3D ]
		Biological Unit 4	[ Jena3D ]
		Biological Unit 5	[ Jena3D ]
		Biological Unit 6	[ Jena3D ]
		Biological Unit 7	[ Jena3D ]

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (5, 31)

Sites (31, 31)

SS Bonds (0, 0)

Cis Peptide Bonds (7, 7)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (2, 8)

PROSITE Motifs (1, 4)

Exons (5, 20)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 4)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (42, 42)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File